openPR Logo
Press release

Netherton Syndrome Pipeline, Therapeutics Assessment, Clinical Trials, Drugs, and Companies 2024

11-14-2024 12:10 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Netherton Syndrome Pipeline

Netherton Syndrome Pipeline

DelveInsight's, "Netherton Syndrome Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Netherton Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore our latest breakthroughs in Netherton Syndrome Research. Learn more about our innovative pipeline today! @ Netherton Syndrome Pipeline Outlook- https://www.delveinsight.com/sample-request/netherton-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Netherton Syndrome Pipeline Report
• In October 2024:- Boehringer Ingelheim- This study is open to people with a skin disease called Netherton syndrome (NS). People can join the study if they are 12 years and older. The purpose of this study is to find out whether a medicine called spesolimab helps people with NS.
• DelveInsight's Netherton Syndrome pipeline report depicts a robust space with 5+ active players working to develop 5+ pipeline therapies for Netherton Syndrome treatment.
• The leading Netherton Syndrome Companies such as TenNor Therapeutics, KBP Biosciences, Debiopharm, Destiny Pharmaa, and others.
• Promising Netherton Syndrome Therapies such as DS-2325a, QRX003, Spesolimab, and others.

Stay informed about the cutting-edge advancements in Netherton Syndrome Treatments. Download for updates and be a part of the revolution in genetic disorder care @ Netherton Syndrome Clinical Trials Assessment- https://www.delveinsight.com/sample-request/netherton-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Netherton Syndrome Emerging Drugs Profile

• QRX003: Quoin Pharmaceuticals
QRX003 is a topical lotion, formulated with a proprietary Invisicare® delivery technology, and contains a broad- spectrum serine protease inhibitor, whose mechanism of action is intended to perform the function of a specific protein, called LEKTI. The absence of LEKTI in Netherton patients leads to excessive skin shedding resulting in a highly porous and compromised skin barrier. QRX003 is designed to lead to a more normalized skin shedding process and the formation of a stronger and more effective skin barrier.

• SXR-1096: Sixera Pharma
SXR1096 is a first-in-class, potent and selective small molecule inhibitor of kallikreins 5, 7 and 14 (KLK5, 7 and 14). The compound is formulated in a proprietary skin cream formulation designed for daily use in patients with rare skin conditions. Due to the inborn lack of the protease inhibitor LEKTI, KLK 5, 7 and 14 are overactive in the outermost layer of the skin in patients with Netherton syndrome. These drug targets can best be reached by applying the pharmaceutical directly on the skin. The disease is manifest from birth and can be life threatening in newborns.

Learn more about Netherton Syndrome Drugs opportunities in our groundbreaking Netherton Syndrome Research and development projects @ Netherton Syndrome Unmet Needs- https://www.delveinsight.com/sample-request/netherton-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Netherton Syndrome Companies
TenNor Therapeutics, KBP Biosciences, Debiopharm, Destiny Pharmaa, and others.

Netherton Syndrome pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
• Oral
• Intravenous
• Subcutaneous
• Parenteral
• Topical

Netherton Syndrome Products have been categorized under various Molecule types such as
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy

Discover the latest advancements in Netherton Syndrome Treatment by visiting our website. Stay informed about how we're transforming the future of genetic disorder @ Netherton Syndrome Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/netherton-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Netherton Syndrome Pipeline Report
• Coverage- Global
• Netherton Syndrome Companies- TenNor Therapeutics, KBP Biosciences, Debiopharm, Destiny Pharmaa, and others.
• Netherton Syndrome Therapies- DS-2325a, QRX003, Spesolimab, and others.
• Netherton Syndrome Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Netherton Syndrome Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

For a detailed overview of our latest research findings and future plans, read the full details of Netherton Syndrome Pipeline on our website @ Netherton Syndrome Drugs and Companies- https://www.delveinsight.com/sample-request/netherton-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Executive Summary
3. Netherton Syndrome: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Netherton Syndrome - DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Drug Name: Company Name
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II/III)
11. QRX003: Quoin Pharmaceuticals
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I/II)
14. SXR-1096: Sixera Pharma
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug Name: Company Name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Netherton Syndrome Key Companies
21. Netherton Syndrome Key Products
22. Netherton Syndrome- Unmet Needs
23. Netherton Syndrome- Market Drivers and Barriers
24. Netherton Syndrome- Future Perspectives and Conclusion
25. Netherton Syndrome Analyst Views
26. Netherton Syndrome Key Companies
27. Appendix

List of Top Selling Market Research Reports in 2024

cardiac monitoring devices market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
embolotherapy market- https://www.delveinsight.com/report-store/embolotherapy-market
keloid market- https://www.delveinsight.com/report-store/keloid-market
orthopedic power devices market- https://www.delveinsight.com/report-store/orthopedic-power-devices-market
shingles market- https://www.delveinsight.com/report-store/shingles-market
short bowel syndrome market- https://www.delveinsight.com/report-store/short-bowel-syndrome-market
surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
testicular neoplasm market- https://www.delveinsight.com/report-store/testicular-cancer-market
dyspepsia market- https://www.delveinsight.com/report-store/dyspepsia-market
liquid biospy for cancer diagnostics market- https://www.delveinsight.com/report-store/liquid-biopsy-in-cancer-diagnostics-market
perennial allergic rhinitis market- https://www.delveinsight.com/report-store/perennial-allergic-rhinitis-market
plaque psoriasis market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
polycystic ovarian syndrome market- https://www.delveinsight.com/report-store/polycystic-ovarian-syndrome-market
respiratory syncytial virus market- https://www.delveinsight.com/report-store/respiratory-syncytial-virus-rsv-market
sarcopenia market- https://www.delveinsight.com/report-store/sarcopenia-market
smoking cessation and nicotine addiction market- https://www.delveinsight.com/report-store/smoking-cessation-and-nicotine-addiction-market
vascular grafts market- https://www.delveinsight.com/report-store/vascular-grafts-market
brucellosis market- https://www.delveinsight.com/report-store/brucellosis-market
catheter stabilization devices market- https://www.delveinsight.com/report-store/catheter-stabilization-securement-device-market
gene therapy in cns disorder market- https://www.delveinsight.com/report-store/gene-therapy-in-cns-disorder-market
nonalcoholic steatohepatitis market- https://www.delveinsight.com/blog/nonalcoholic-steatohepatitis-nash-highly-epidemic
pelvic organ prolapse market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
pertussis market- https://www.delveinsight.com/report-store/pertussis-market
sglt2 inhibitors market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
viscosupplementation devices market- https://www.delveinsight.com/report-store/viscosupplementation-devices-market
bacterial meningitis market- https://www.delveinsight.com/report-store/meningococcal-meningitis-market
carcinoid syndrome market- https://www.delveinsight.com/report-store/carcinoid-tumor-market
cxcr inhibitors market- https://www.delveinsight.com/report-store/selective-inhibitor-of-the-cxcr4-chemokine-receptor-market-forecast
endoscopic ultrasound market- https://www.delveinsight.com/report-store/endoscopic-ultrasound-market
hdac inhibitors market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
myeloproliferative neoplasms market- https://www.delveinsight.com/report-store/myeloproliferative-neoplasms-market
plasmodium vivax malaria market- https://www.delveinsight.com/report-store/plasmodium-vivax-malaria-market
vascular access devices market- https://www.delveinsight.com/report-store/vascular-access-device-market
venous ulcer market- https://www.delveinsight.com/report-store/venous-leg-ulcer-market
ventral hernia market- https://www.delveinsight.com/report-store/hernia-repair-devices-market
vitreoretinal surgery devices market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
wound healing devices market- https://www.delveinsight.com/report-store/wound-healing-devices-market
novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
phototherapies for psoriasis market- https://www.delveinsight.com/report-store/phototherapies-for-psoriasis-market
pulmonary emphysema market- https://www.delveinsight.com/report-store/chronic-obstructive-pulmonary-disease-copd-market
urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
overactive bladder syndrome market- https://www.delveinsight.com/report-store/overactive-bladder-market
pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
somatotropin deficiency market- https://www.delveinsight.com/report-store/somatotropin-deficiency-market
thrombectomy devices market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
tourette syndrome market- https://www.delveinsight.com/report-store/tourette-syndrome-market
external defibrillators market- https://www.delveinsight.com/report-store/defibrillator-market
plantar fasciitis market- https://www.delveinsight.com/report-store/plantar-fasciitis-market
scoliosis market- https://www.delveinsight.com/report-store/scoliosis-market
tendonitis market- https://www.delveinsight.com/report-store/tendonitis-market
urinary catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
lice infestations market- https://www.delveinsight.com/report-store/lice-infestations-market
peripheral nerve injuries market- https://www.delveinsight.com/report-store/peripheral-nerve-repair-devices-market
sepsis market- https://www.delveinsight.com/report-store/sepsis-market
stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
varicose vein treatment devices market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
chronic neuropathic pain market- https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market
fabry disease market- https://www.delveinsight.com/report-store/fabry-disease-market
consulting solutions- https://www.delveinsight.com/consulting
pacemakers market- https://www.delveinsight.com/report-store/pacemakers-market
positive airway pressure device market- https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
transcatheter heart valve replacement devices market- https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market
lymphoedema market- https://www.delveinsight.com/report-store/lymphedema-market
seltorexant drug market- https://www.delveinsight.com/report-store/major-depressive-disorder-market
surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
meningococcal meningitis market- https://www.delveinsight.com/report-store/meningococcal-meningitis-market
surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
surgical lasers market- https://www.delveinsight.com/report-store/surgical-lasers-market
TCR therapy market- https://www.delveinsight.com/report-store/t-cell-receptor-tcr-therapy-market
diabetic wound market- https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
indwelling catheters market- https://www.delveinsight.com/report-store/indwelling-catheters-market
Nontuberculous Mycobacterial Market- https://www.delveinsight.com/report-store/nontuberculous-mycobacterial-ntm-infections-market
intraocular lens market https://www.delveinsight.com/report-store/intraocular-lens-market
orthopedic splints device market- https://www.delveinsight.com/report-store/orthotic-devices-market
transcatheter treatment market- https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market
antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
NK cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
total knee arthroplasty market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market
skin neoplasm market- https://www.delveinsight.com/blog/skin-cancer-treatment-market-and-key-companies
asperger syndrome market- https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Netherton Syndrome Pipeline, Therapeutics Assessment, Clinical Trials, Drugs, and Companies 2024 here

News-ID: 3735694 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Netherton

Evolving Market Trends In The Netherton Syndrome Industry: Advancements In Serin …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. What Is the Expected Netherton Syndrome Market Size During the Forecast Period? The market size of the Netherton syndrome has experienced significant growth over the recent years. It is projected to escalate from $1.15 billion in 2024 to $1.27 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.2%. The notable growth
Netherton Syndrome Market Growth to Accelerate in Forecast Period (2023-2032) | …
DelveInsight's "Netherton Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Netherton Syndrome, historical and forecasted epidemiology as well as the Netherton Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. Explore the intricate details of the Netherton Syndrome Market: Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive Netherton Syndrome Market Forecast. Click here
Netherton Syndrome Clinical Trials, Pipeline Insights, Treatment Drugs, and Comp …
DelveInsight's, "Netherton Syndrome- Pipeline Insight, 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Netherton Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Netherton Syndrome Research. Learn more about
Netherton Syndrome Pipeline Drugs, FDA Approvals, and Companies 2024
DelveInsight's, "Netherton Syndrome- Pipeline Insight, 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Netherton Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Netherton Syndrome Research. Learn more about
Netherton Syndrome Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MO …
DelveInsight's, "Netherton Syndrome- Pipeline Insight, 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Netherton Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Netherton Syndrome Research. Learn more about
Netherton Syndrome Market Size, Share, Trends, Insights, Growth 2032
Introduction A. Overview of Netherton Syndrome Netherton syndrome is a rare genetic disorder that primarily affects the skin, hair, and immune system. This condition is characterized by ichthyosis linearis circumflexa (red, scaly skin), trichorrhexis invaginata (bamboo hair), and a predisposition to atopic conditions such as eczema, asthma, and allergies. The syndrome is caused by mutations in the SPINK5 gene, which encodes the LEKTI protein, crucial for skin barrier function. Due to